166 related articles for article (PubMed ID: 21046494)
1. The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
Balzli CL; McCormick CC; Caballero AR; Tang A; O'Callaghan RJ
Adv Ther; 2010 Dec; 27(12):933-40. PubMed ID: 21046494
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
[TBL] [Abstract][Full Text] [Related]
4. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
7. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
Assil KK; Frucht-Perry J; Ziegler E; Schanzlin DJ; Schneiderman T; Weinreb RN
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3216-20. PubMed ID: 1748553
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
9. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
[TBL] [Abstract][Full Text] [Related]
11. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Lauffenburger MD; Cohen KL
Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
13. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
[TBL] [Abstract][Full Text] [Related]
15. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
[TBL] [Abstract][Full Text] [Related]
16. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels.
Frucht-Pery J; Raiskup F; Mechoulam H; Shapiro M; Eljarrat-Binstock E; Domb A
Cornea; 2006 Dec; 25(10):1182-6. PubMed ID: 17172895
[TBL] [Abstract][Full Text] [Related]
17. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.
Assil KK; Zarnegar SR; Fouraker BD; Schanzlin DJ
Am J Ophthalmol; 1992 Apr; 113(4):418-23. PubMed ID: 1558116
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Pseudomonas keratitis in the rabbit with antibiotic-steroid combinations.
Bohigian GM; Foster CS
Invest Ophthalmol Vis Sci; 1977 Jun; 16(6):553-6. PubMed ID: 405346
[TBL] [Abstract][Full Text] [Related]
20. Intracanalicular collagen implants enhance topical antibiotic bioavailability.
Gilbert ML; Wilhelmus KR; Osato MS
Cornea; 1986; 5(3):167-71. PubMed ID: 2980835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
